FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / indemnification-benchmarking-memo.docx
indemnification-benchmarking-memo.docx · 1018-00004

Parties

HARKNESS LLP
Penterra Pharmaceuticals Corp
Callahan LLP
Northwell Biosciences Corp
Tralvendo Therapeutics Corp
Caelum Therapeutics Corp
Marlowe Asset Management BioSciences Corp

Dates

April 24, 2023
April 7, 2023

Amounts

$80,000,000
$500,000
$15,000,000
$12,500,000
$10,000,000
$5,000,000
$20,000,000
$40,000,000
$120,000,000
$50,000,000

Obligations

This structure incentivizes sites to seek advance authorization for elective deviations while protecting investigators who must act swiftly in emergent clinical situations
In the site indemnity context, a "per-site/per-occurrence" cap limits the maximum amount that the site network must indemnify the sponsor for any single claim arising at a single site